These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 30608696)

  • 1. Unraveling How Membrane Nanostructure Changes Impact the Eye Irritation of Nonionic Alkyl Ethoxylate Surfactants.
    Hu X; Liao M; Shen K; Ding K; Campana M; van der Kamp S; McInnes EF; Padia F; Lu JR
    ACS Appl Mater Interfaces; 2023 Dec; 15(50):59087-59098. PubMed ID: 38078441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoemulsion-Based Orodispersible Film Formulation of Guava Leaf Oil for Inhibition of Oral Cancer Cells.
    Weerapol Y; Manmuan S; Chuenbarn T; Limmatvapirat S; Tubtimsri S
    Pharmaceutics; 2023 Nov; 15(11):. PubMed ID: 38004609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical studies of novel sugar fatty acid esters based on (
    Snoch W; Jarek E; Milivojevic D; Nikodinovic-Runic J; Guzik M
    Front Bioeng Biotechnol; 2023; 11():1112053. PubMed ID: 36845180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane disruption of Fusarium oxysporum f. sp. niveum induced by myriocin from Bacillus amyloliquefaciens LZN01.
    Wang H; Wang Z; Liu Z; Wang K; Xu W
    Microb Biotechnol; 2021 Mar; 14(2):517-534. PubMed ID: 32954686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Sucrose Laurate as an Intestinal Permeation Enhancer for Macromolecules: Ex Vivo and In Vivo Studies.
    McCartney F; Rosa M; Brayden DJ
    Pharmaceutics; 2019 Oct; 11(11):. PubMed ID: 31683652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New micelle myricetin formulation for ocular delivery: improved stability, solubility, and ocular anti-inflammatory treatment.
    Sun F; Zheng Z; Lan J; Li X; Li M; Song K; Wu X
    Drug Deliv; 2019 Dec; 26(1):575-585. PubMed ID: 31172843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers.
    Rege BD; Kao JP; Polli JE
    Eur J Pharm Sci; 2002 Sep; 16(4-5):237-46. PubMed ID: 12208453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial transport of drugs in cell culture. VII: Effects of pharmaceutical surfactant excipients and bile acids on transepithelial permeability in monolayers of human intestinal epithelial (Caco-2) cells.
    Anderberg EK; Nyström C; Artursson P
    J Pharm Sci; 1992 Sep; 81(9):879-87. PubMed ID: 1432633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonionic surfactants increase digoxin absorption in Caco-2 and MDCKII MDR1 cells: Impact on P-glycoprotein inhibition, barrier function, and repeated cellular exposure.
    Al-Ali AAA; Steffansen B; Holm R; Nielsen CU
    Int J Pharm; 2018 Nov; 551(1-2):270-280. PubMed ID: 30240828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloud point of nonionic surfactants: modulation with pharmaceutical excipients.
    Na GC; Yuan BO; Stevens HJ; Weekley BS; Rajagopalan N
    Pharm Res; 1999 Apr; 16(4):562-8. PubMed ID: 10227713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of solubilizing excipients on permeation of poorly water-soluble compounds across Caco-2 cell monolayers.
    Saha P; Kou JH
    Eur J Pharm Biopharm; 2000 Nov; 50(3):403-11. PubMed ID: 11072198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery.
    Jiao J
    Adv Drug Deliv Rev; 2008 Dec; 60(15):1663-73. PubMed ID: 18845195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure to a Nonionic Surfactant Induces a Response Akin to Heat-Shock Apoptosis in Intestinal Epithelial Cells: Implications for Excipients Safety.
    Cavanagh RJ; Smith PA; Stolnik S
    Mol Pharm; 2019 Feb; 16(2):618-631. PubMed ID: 30608696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of surfactant excipients in oral drug formulations.
    Maher S; Geoghegan C; Brayden DJ
    Adv Drug Deliv Rev; 2023 Nov; 202():115086. PubMed ID: 37739041
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.